[1]
S. Sato, “The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE: PolaRCHP vs. RCHOP for older patients”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025070, Oct. 2025.